ArticleBMC women's health2026
Different types of abdominal wall endometriosis have different clinical features and surgical outcomes.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo compare the differences in clinical characteristics between different types of abdominal wall endometriosis (AWE) according to the invasive levels of tissue mass.
methods122 patients, who had undergone resection of AWE lesions at our hospital from January 2011 to January 2023, were retrospectively analyzed. The patients were divided into three types according to their deepest level of lesion invasion. Type I designated invasion of skin and subcutaneous tissue; type II, of the fascial rectus abdominis; and type III, of the muscle and/or peritoneum. The general conditions, clinical manifestations, auxiliary examinations, surgical and postoperative conditions, and recurrence, were classified, compared, and analyzed.
resultsOf the 122 patients, type I patients accounted for 23.0%, type II patients for 45.1%, and type III for 31.9%. With respect to group comparisons, we observed that as the location of the mass deepened, the size of the mass increased (P < 0.001), the rate of concurrent pelvic endometriosis increased (0%, 7.2%, 10.3%, respectively), the rate of multiple lesions became elevated (3.6%, 10.9%, 15.4%, respectively), the rate of mesh implantation increased (P = 0.0012), and the risk of drainage placement (P = 0.0012) was enhanced, the length of postoperative hospital stay (P = 0.0042) was lengthened, the number of postoperative fever cases (3.6%, 3.6%, 15.4%, respectively) increased. With a median follow-up time of 93 months, only 2 cases, including 1 case in type I and 1 case in type II, were diagnosed as recurrence. Rates were not statistically significant by the different groups.
conclusionThe different types of AWE have an impact on surgical results, but no impact on the chance of recurrence. Type III AWE carries more severe clinical manifestations, larger lesion size, longer operative time, higher necessity of mesh implantation, and longer postoperative recovery process. Complete resection of AWE lesion is the main therapeutically approach and shows relatively low long-term recurrency rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.